Kashyap Patel, MD, CEO of Carolina Blood and Cancer Care Associates, and current president of the Community Oncology Alliance (COA), speaks on what he’s looking forward to for his first in-person Community Oncology Conference as COA president.
I’m looking forward to seeing attendees and taking part in live in-person discussions at the 2022 Community Oncology Conference, said Kashyap Patel, MD, CEO of Carolina Blood and Cancer Care Associates, and current president of the Community Oncology Alliance (COA)
Transcript
Entering your second year as president of COA and first year with the Community Oncology Conference in person, what should attendees look forward to at the upcoming meeting?
This is a very incredible year, because in the last 2 years we've seen so many challenges—a once in 100 years global public health emergency, and I felt I was almost going to be the virtual president for 2 years.
Now that things are opening up, I'll now be somebody who can touch, feel, and sense. I’m a people's person, so I'm looking forward to seeing people in person, hugging, touching, talking, and feeling like a human being. I'm telling you, 2 years have literally deprived us of our sense of being who we are as a human being, and I'm looking forward to really live exchange interactions—an in-person meeting to really make a difference in people's lives.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Targeting Progression: Amivantamab’s Role in NSCLC After Osimertinib
October 24th 2024Amivantamab's role in non–small cell lung cancer (NSCLC) has been a highlight of the lung cancer space this year, with the 2 most recent approvals based on data from the MARIPOSA and MARIPOSA-2 trials.
Read More
Recognizing Symptoms of Myeloproliferative Neoplasms and Clinical Trial Challenges
October 24th 2024There can be a delay in diagnosis of myeloproliferative neoplasms as the symptoms of the diseases can be variable and common, such as fatigue, migraines, and difficulty concentrating, explained Ruben Mesa, MD, of Atrium Health.
Read More